|
|
||||||||||||||
|
|
|||||||||||||||
| ||||||||||||||
Competing interest: JC is a Director and JC and JDFW are shareholders and consultants of D-Gen Limited, an academic spin-out company working in the field of prion disease diagnosis, decontamination and therapeutics. D-Gen markets one of the routine antibodies (ICSM 35) used in this study.
| ||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |